<DOC>
	<DOCNO>NCT01454453</DOCNO>
	<brief_summary>Drugs amisulpride , know antipsychotic drug , use treat troublesome distressing symptom old people . Although drug beneficial , associated side effect , particularly patient dementia schizophrenia- like illness . There urgent clinical need understand case , guide treatment strategy . This study aim utilise brain imaging technique measure action antipsychotic drug brain explore cause susceptibility old people dementia schizophrenia-like illness , translate finding direct patient benefit . The aim study investigate compare relationship action amisulpride brain site clinical response ( symptom reduction side effect profile ) first 10 week amisulpride treatment two patient group - Alzheimer 's disease schizophrenia-like illness . Imaging data combine data drug dosage , level drug bloodstream clinical response ( symptom reduction motor side effect ) dose titration . Non-linear mixed effect model use establish minimum clinically effective dose amisulpride , optimum dose range impact variability covariates exposure-response relationship 2 patient group This information use make prediction amisulpride prescribe antipsychotic drug two patient group .</brief_summary>
	<brief_title>Optimisation Antipsychotic Drug Use Older People</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<criteria>Inclusion Criteria Treatment Control ( antipsychotic free ) Group Schizophrenia meet diagnostic criterion schizophrenialike illness age 60 95 year age score &lt; 6 Geriatric depression scale Alzheimer 's meet diagnostic criterion AD score &lt; =4 Modified Hachinski Ischaemia Scale score &lt; 8 modify version UPDRS age 60 95 year age score &lt; 6 Geriatric depression scale Exclusion Criteria Treatment Group Schizophrenia current past history addiction , traumatic brain injury epilepsy prescribe drug interferes brain dopamine past 2 week ( 6 week depot antipsychotic medication ) . medical condition might affect Ability tolerate brain scan unable give inform consent Alzheimer 's current past history psychiatric illness , traumatic brain injury epilepsy prescribe antipsychotic oral drug interferes brain dopamine function within past 2 week ( 6 week depot antipsychotic medication ) . medical condition might affect person 's ability tolerate brain scan Control ( antipsychotic free ) Group Schizophrenia Prescribed psychotropic medication unable give inform consent Alzheimer 's â€¢ Prescribed psychotropic medication</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>amisulpride</keyword>
	<keyword>receptor occupancy</keyword>
	<keyword>antipsychotic sensitivity</keyword>
</DOC>